Showing results (21-30 of 48) with videos related to
Sort By:
Pageof 5
Life Sciences|January 1, 1991
The blood pressure and renal responses to SCH 34826, a neutral metalloendopeptidase inhibitor, and C-ANF (4-23) in Doca-salt hypertensive ratsS Vemulapalli, P J Chiu, A Brown, et al.The Journal of Pharmacology and Experimental Therapeutics|September 1, 1992
Phosphoramidon abolishes the increases in endothelin-1 release induced by ischemia-hypoxia in isolated perfused guinea pig lungsS Vemulapalli, M Rivelli, P J Chiu, et al.Hypertension (Dallas, Tex. : 1979)|February 1, 1990
Atrial natriuretic factor-potentiating and antihypertensive activity of SCH 34826. An orally active neutral metalloendopeptidase inhibitorE J Sybertz, P J Chiu, S Vemulapalli, et al.Journal of Cardiovascular Pharmacology|December 1, 1991
Modulation of circulating endothelin levels in hypertension and endotoxemia in ratsS Vemulapalli, P J Chiu, M Rivelli, et al.Pacing and Clinical Electrophysiology : PACE|November 18, 2025
Evaluating Pulsed Field Ablation for Atrial Fibrillation: A Systematic Review and Meta-Analysis of Procedural OutcomesPoojan Prajapati, Hema S Vemulapalli, Juan F Rodriguez-Riascos, et al.Life Sciences|January 1, 1993
Disparate effects of phosphoramidon on blood pressure in SHR and DOCA-salt hypertensive ratsS Vemulapalli, R W Watkins, A Brown, et al.The Journal of Pharmacology and Experimental Therapeutics|June 1, 1992
Sympathoadrenal stimulation, not endothelin, plays a role in acute pressor response to cyclosporine in anesthetized ratsP J Chiu, S Vemulapalli, C Sabin, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|September 1, 1993
Inhibition of endothelial derived relaxing factor (EDRF) aggravates ischemic acute renal failure in anesthetized ratsM S Chintala, P J Chiu, S Vemulapalli, et al.Life Sciences|November 23, 1987
The responses of atrial natriuretic factor concentrations to acute volume changes in conscious ratsP J Chiu, S Vemulapalli, M Policelli, et al.Progress in Clinical and Biological Research|January 1, 1986
AGEPC, a vasodilator phospholipid with profound circulatory actionsE J Sybertz, R W Watkins, S Vemulapalli, et al.Pageof 5